The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://www.nature.com/articles/s41416-021-01422-w.pdf
Reference82 articles.
1. Meisel, J. L., Venur, V. A., Gnant, M. & Carey, L. Evolution of targeted therapy in breast cancer: where precision medicine began. Am. Soc. Clin. Oncol. Educ. Book 38, 78–86 (2018).
2. Condorelli, R., Mosele, F., Verret, B., Bachelot, T., Bedard, P. L., Cortes, J. et al. Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Ann. Oncol. 30, 365–373 (2019).
3. Overman, M. J., Modak, J., Kopetz, S., Murthy, R., Yao, J. C., Hicks, M. E. et al. Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J. Clin. Oncol. 31, 17–22 (2013).
4. Poulet, G., Massias, J. & Taly, V. Liquid biopsy: general concepts. Acta Cytol. 63, 449–455 (2019).
5. Chae, Y. K., Davis, A. A., Jain, S., Santa-Maria, C., Flaum, L., Beaubier, N. et al. Concordance of genomic alterations by next-generation sequencing in tumor tissue versus circulating tumor DNA in breast cancer. Mol. Cancer Ther. 16, 1412–1420 (2017).
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR-mutated metastatic non-small cell lung cancer;Scientific Reports;2024-08-06
2. Use of ctDNA in early breast cancer: analytical validity and clinical potential;npj Breast Cancer;2024-06-19
3. Status of breast cancer detection in young women and potential of liquid biopsy;Frontiers in Oncology;2024-05-21
4. Advances in Thermal Imaging: A Convolutional Neural Network Approach for Improved Breast Cancer Diagnosis;2024 International Conference on Distributed Computing and Optimization Techniques (ICDCOT);2024-03-15
5. Rational thresholding of circulating tumor DNA concentration for improved surveillance of metastatic breast cancer;ESMO Open;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3